Gianluca Campo to Myocardial Infarction
This is a "connection" page, showing publications Gianluca Campo has written about Myocardial Infarction.
Connection Strength
0.249
-
Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol. PLoS One. 2021; 16(7):e0255263.
Score: 0.072
-
Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial). Am J Cardiol. 2018 05 01; 121(9):1039-1045.
Score: 0.057
-
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). J Am Coll Cardiol. 2014 Feb 18; 63(6):506-12.
Score: 0.042
-
Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol. 2010 Jun; 99(6):345-57.
Score: 0.033
-
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):203-210.
Score: 0.017
-
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction. J Med Chem. 2018 08 23; 61(16):7131-7143.
Score: 0.015
-
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med. 2018 07 19; 379(3):250-259.
Score: 0.014